UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Community implications for gun violence prevention during co-occurring pandemics; a qualitative and computational analysis study

Preventive medicine, 2022-12, Vol.165 (Pt A), p.107263, Article 107263

2022

Volltextzugriff (PDF)

Ultrasensitive plasma-based monitoring of tumor burden using machine-learning-guided signal enrichment

Nature medicine, 2024-06, Vol.30 (6), p.1655-1666

2024

Volltextzugriff (PDF)

Abstract 5709: Whole genome error-corrected sequencing for sensitive circulating tumor DNA cancer monitoring

Cancer research (Chicago, Ill.), 2023-04, Vol.83 (7_Supplement), p.5709-5709

2023

Volltextzugriff (PDF)

An alternative inhibitor overcomes resistance caused by a mutation of the epidermal growth factor receptor

Cancer research (Chicago, Ill.), 2005-08, Vol.65 (16), p.7096-7101

2005

Volltextzugriff (PDF)

BIM mediates EGFR tyrosine kinase inhibitor-induced apoptosis in lung cancers with oncogenic EGFR mutations

PLoS medicine, 2007-10, Vol.4 (10), p.1669-79; discussion 1680

2007

Volltextzugriff (PDF)

Differential Effects of Gefitinib and Cetuximab on Non–small-cell Lung Cancers Bearing Epidermal Growth Factor Receptor Mutations

JNCI : Journal of the National Cancer Institute, 2005-08, Vol.97 (16), p.1185-1194

2005

Volltextzugriff (PDF)

Effects of Erlotinib in EGFR Mutated Non-Small Cell Lung Cancers with Resistance to Gefitinib

Clinical cancer research, 2008-11, Vol.14 (21), p.7060-7067

2008

Volltextzugriff (PDF)

EGFR Mutation and Resistance of Non–Small-Cell Lung Cancer to Gefitinib

The New England journal of medicine, 2005-02, Vol.352 (8), p.786-792

2005

Volltextzugriff (PDF)

Dysregulation of the C/EBPα Differentiation Pathway in Human Cancer

Journal of clinical oncology, 2009-02, Vol.27 (4), p.619-628

2009

Volltextzugriff (PDF)

Case Fatality Rate of Cancer Patients with COVID-19 in a New York Hospital System

Cancer discovery, 2020-07, Vol.10 (7), p.935-941

2020

Volltextzugriff (PDF)

Diet as a therapeutic tool in chronic gastrointestinal disorders: Lessons from the FODMAP journey

Journal of gastroenterology and hepatology, 2022-04, Vol.37 (4), p.644-652

2022

Volltextzugriff (PDF)

Transcriptional profiling identifies cyclin D1 as a critical downstream effector of mutant epidermal growth factor receptor signaling

Cancer research (Chicago, Ill.), 2006-12, Vol.66 (23), p.11389-11398

2006

Volltextzugriff (PDF)

Resistance to an Irreversible Epidermal Growth Factor Receptor (EGFR) Inhibitor in EGFR-Mutant Lung Cancer Reveals Novel Treatment Strategies

Cancer research (Chicago, Ill.), 2007-11, Vol.67 (21), p.10417-10427

2007

Volltextzugriff (PDF)

Combined Vascular Endothelial Growth Factor Receptor and Epidermal Growth Factor Receptor (EGFR) Blockade Inhibits Tumor Growth in Xenograft Models of EGFR Inhibitor Resistance

Clinical cancer research, 2009-05, Vol.15 (10), p.3484-3494

2009

Volltextzugriff (PDF)

CARM1 is required for proper control of proliferation and differentiation of pulmonary epithelial cells

Development (Cambridge), 2010-07, Vol.137 (13), p.2147-2156

2010

Volltextzugriff (PDF)

Exon 19 Deletion Mutations of Epidermal Growth Factor Receptor Are Associated with Prolonged Survival in Non–Small Cell Lung Cancer Patients Treated with Gefitinib or Erlotinib

Clinical cancer research, 2006-07, Vol.12 (13), p.3908-3914

2006

Volltextzugriff (PDF)

EGFR T790M: revealing the secrets of a gatekeeper

Lung cancer (Auckland), 2017-01, Vol.8, p.147-159

2017

Volltextzugriff (PDF)

Health equity regional symposia: Convening local stakeholders to address health disparities in the US

Journal of clinical oncology, 2024-06, Vol.42 (16_suppl), p.e13695-e13695

2024

Volltextzugriff (PDF)

EGFR Mutation and Response of Lung Cancer to Gefitinib

The New England journal of medicine, 2005-05, Vol.352 (20), p.2136-2136

2005

Volltextzugriff (PDF)

Oncological and surgical outcome of total laryngectomy in combination with neck dissection in the elderly

European archives of oto-rhino-laryngology, 2016-07, Vol.273 (7), p.1825-1833

2016

Volltextzugriff (PDF)

RON Kinase Is a Novel Therapeutic Target for Philadelphia-Negative Myeloproliferative Neoplasms

Blood, 2021-11, Vol.138 (Supplement 1), p.1462-1462

2021

Volltextzugriff (PDF)

ANGPTL7 and Its Role in IOP and Glaucoma

Investigative ophthalmology & visual science, 2024-03, Vol.65 (3), p.22-22

2024

Volltextzugriff (PDF)

Crizotinib Has Preclinical Efficacy in Philadelphia-Negative Myeloproliferative Neoplasms

Clinical cancer research, 2023-03, Vol.29 (5), p.943-956

2023

Volltextzugriff (PDF)

Frequent downregulation of the transcription factor Foxa2 in lung cancer through epigenetic silencing

Lung cancer (Amsterdam, Netherlands), 2012-07, Vol.77 (1), p.31-37

2012

Volltextzugriff (PDF)

The CoVID‐TE risk assessment model for venous thromboembolism in hospitalized patients with cancer and COVID‐19

Journal of thrombosis and haemostasis, 2021-10, Vol.19 (10), p.2522-2532

2021

Volltextzugriff (PDF)

1 – 25 von 83

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(66)
Mit Volltextzugriff
(77)

Publikationsform

Sprache

Englisch
(83)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(51)
Science & Technology
(51)
Humans
(39)
Oncology
(25)
Biological And Medical Sciences
(19)
Lung Neoplasms - Genetics
(19)
Medical Sciences
(18)
Mutation
(15)
Animals
(14)
Carcinoma, Non-Small-Cell Lung - Genetics
(14)
Lung Neoplasms - Drug Therapy
(13)
Pharmacology. Drug Treatments
(13)
Carcinoma, Non-Small-Cell Lung - Drug Therapy
(11)
Female
(11)
Male
(11)
Receptor, Epidermal Growth Factor - Genetics
(11)
Lung Cancer
(10)
Lung Neoplasms - Pathology
(10)
Tumors
(10)
Aged
(9)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Community implications for gun violence prevention during co-occurring pandemics; a qualitative and computational analysis study

Ultrasensitive plasma-based monitoring of tumor burden using machine-learning-guided signal enrichment

Abstract 5709: Whole genome error-corrected sequencing for sensitive circulating tumor DNA cancer monitoring

An alternative inhibitor overcomes resistance caused by a mutation of the epidermal growth factor receptor

BIM mediates EGFR tyrosine kinase inhibitor-induced apoptosis in lung cancers with oncogenic EGFR mutations

Differential Effects of Gefitinib and Cetuximab on Non–small-cell Lung Cancers Bearing Epidermal Growth Factor Receptor Mutations

Effects of Erlotinib in EGFR Mutated Non-Small Cell Lung Cancers with Resistance to Gefitinib

EGFR Mutation and Resistance of Non–Small-Cell Lung Cancer to Gefitinib

Dysregulation of the C/EBPα Differentiation Pathway in Human Cancer

Case Fatality Rate of Cancer Patients with COVID-19 in a New York Hospital System

Diet as a therapeutic tool in chronic gastrointestinal disorders: Lessons from the FODMAP journey

Transcriptional profiling identifies cyclin D1 as a critical downstream effector of mutant epidermal growth factor receptor signaling

Resistance to an Irreversible Epidermal Growth Factor Receptor (EGFR) Inhibitor in EGFR-Mutant Lung Cancer Reveals Novel Treatment Strategies

Combined Vascular Endothelial Growth Factor Receptor and Epidermal Growth Factor Receptor (EGFR) Blockade Inhibits Tumor Growth in Xenograft Models of EGFR Inhibitor Resistance

CARM1 is required for proper control of proliferation and differentiation of pulmonary epithelial cells

Exon 19 Deletion Mutations of Epidermal Growth Factor Receptor Are Associated with Prolonged Survival in Non–Small Cell Lung Cancer Patients Treated with Gefitinib or Erlotinib

EGFR T790M: revealing the secrets of a gatekeeper

Health equity regional symposia: Convening local stakeholders to address health disparities in the US

EGFR Mutation and Response of Lung Cancer to Gefitinib

Oncological and surgical outcome of total laryngectomy in combination with neck dissection in the elderly

RON Kinase Is a Novel Therapeutic Target for Philadelphia-Negative Myeloproliferative Neoplasms

ANGPTL7 and Its Role in IOP and Glaucoma

Crizotinib Has Preclinical Efficacy in Philadelphia-Negative Myeloproliferative Neoplasms

Frequent downregulation of the transcription factor Foxa2 in lung cancer through epigenetic silencing

The CoVID‐TE risk assessment model for venous thromboembolism in hospitalized patients with cancer and COVID‐19

Suchergebnisse filtern